奥比努图祖马布在活跃性狼性炎中的有效性和安全性
Richard A Furie1, Brad H Rovin2, Jay P Garg3
1Division of Rheumatology, Northwell Health, Great Neck, NY.
The New England journal of medicine
|February 10, 2025
概括
与安慰剂相比,在狼性炎患者中,OBINUTUZUMAB显著改善了脏反应. 这种人性化的抗CD20抗体为狼性炎提供了更有效的治疗选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 狼性炎是系统性红斑狼的严重并发症.
- 狼性炎的标准疗法在实现完全反应方面存在局限性.
- 奥本图祖马布是一种II型抗CD20单克隆抗体,在第二阶段试验中显示出有前途.
研究的目的:
- 为了评估obinutuzumab加上标准治疗在患有活跃狼性炎的患者的疗效和安全性.
- 为了确定obinutuzumab是否与安慰剂相比改善了完整脏反应率.
主要方法:
- 第三阶段,随机对照试验,涉及271名活检证明有活性的狼性炎的成年人.
- 患者接受了obinutuzumab或安慰剂,结合标准治疗 (mycophenolate mofetil和口服普雷迪尼松).
- 主要终点是76周完整的反应,定义为特定的尿蛋白与肌素的比率和估计的淋巴膜过率标准.
主要成果:
- 接受欧比努祖马布治疗的46.4%的患者实现了完全的脏反应,而安慰剂组的33.1% (P=0.02).
- 关键的二次终点,包括持续的脏反应与较低的普得尼松剂量和改善的尿蛋白与肌氨酸的比率,也显着更好地与obinutuzumab.
- 没有发现任何意想不到的安全信号,尽管严重的不良事件,主要是感染,在obinutuzumab治疗中更频繁.
结论:
- 与标准治疗结合使用的奥本图祖马布比单独使用标准治疗更有效,可以在患有活跃狼性炎的成年人中实现完整的反应.
- 这项研究支持obinutuzumab作为一种有价值的治疗选择,用于管理狼性炎.
- 进一步的研究可能会探索优化奥比努祖马布剂量和管理相关风险.
更多相关视频
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...